The patient who received basiliximab (Simulect) just before and on the fourth day after his kidney transplant asks how long he will have to take the prescribed oral mycophenolate (CellCept). What is your best response?
A. "Because acute rejection is most common during the first 12 weeks after transplantation, you can stop the drug after 3 months."
B. "We will monitor your white blood cell count and when lymphocytes remain lower than normal for a year, we will discontinue the drug."
C. "Because you will be at an increased risk for infection, you will need to continue taking this drug for the rest of your life."
D. "Because this drug prevents rejection, you will need to take the drug as long as the new kidney continues to function."